A case of rituximab-induced hepatitis.


A case of hepatitis in a patient receiving rituximab for ITP is reported. After an extensive workup, no infectious or autoimmune etiology could be found. The authors believe that this represents a case of drug-induced hepatitis, which has not been reported for this agent in the past.

DOI: 10.1089/cbr.2010.0806

Cite this paper

@article{Prete2010ACO, title={A case of rituximab-induced hepatitis.}, author={Christopher Joseph Del Prete and Neil S Cohen}, journal={Cancer biotherapy & radiopharmaceuticals}, year={2010}, volume={25 6}, pages={747-8} }